Figure S5 from SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance

Abstract

<p>Combined pharmacological targeting of PI3K and SGKs at a constant inhibitors ratio does not result in synergistic activity.</p>